Brilinta and Compazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Brilinta (ticagrelor) and Compazine (prochlorperazine maleate). Common drug interactions include angina pectoris among females and hypertransaminasaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Brilinta and Compazine. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Brilinta?

Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.

What is Compazine?

Compazine has active ingredients of prochlorperazine maleate. It is often used in indigestion. eHealthMe is studying from 13,646 Compazine users. Check the latest studies of Compazine.

On Jul, 21, 2026

18 people who take Brilinta and Compazine together, and have interactions are studied.

Brilinta and Compazine drug interactions.

What are the common drug interactions of Brilinta and Compazine, by gender? *:

female:

Angina pectoris (chest pain due to ischemia of the heart muscle)
Abdominal discomfort
Arthropathy
Back pain
Bone disorder
Drug intolerance (drug sensitivity)
Fatigue (feeling of tiredness)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hypoaesthesia (reduced sense of touch or sensation)
Lymphadenopathy (disease or enlargement of lymph nodes)

male:

Hypertransaminasaemia
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Myalgia (muscle pain)
Procedural pain
Pyrexia (fever)
Sepsis (a severe blood infection that can lead to organ failure and death)
Urinary tract infection
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
Urticaria (rash of round, red welts on the skin that itch intensely)
Arrhythmia (irregular heartbeat)

What are the common drug interactions of Brilinta and Compazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal discomfort
Arthropathy
Bone disorder
Fatigue (feeling of tiredness)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

50-59:

n/a

60+:

Hypertransaminasaemia
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Drug intolerance (drug sensitivity)
Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
Escherichia infection (bacterial infection by escherichia coli)
Hypoaesthesia (reduced sense of touch or sensation)
Lymphadenopathy (disease or enlargement of lymph nodes)
Myalgia (muscle pain)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Procedural pain

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 4 people, 22.22%
Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 3 people, 16.67%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 16.67%
Acute Myeloid Leukaemia (In Remission): 2 people, 11.11%
Nausea (feeling of having an urge to vomit): 2 people, 11.11%
Type 2 Diabetes: 1 person, 5.56%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 5.56%
Bleeding Disorders: 1 person, 5.56%
Breast Cancer Female: 1 person, 5.56%
Chest Pain: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Brilinta and Compazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously